The Journal of Organic Chemistry
Article
(s, 9H). 13C NMR (100 MHz, CDCl3): δ 144.0, 137.7, 133.4, 133.4,
133.0, 132.6, 129.6, 128.7, 128.3, 128.1, 127.6, 127.5, 127.1, 126.9,
125.9, 121.6, 104.9, 97.6, −0.3. HRMS Calcd for C21H20Si: 300.1334.
Found: 300.1335.
Synthesis of 3,6,9,12-Tetrakis(6-tert-butylphenanthren-2-
yl)chrysene (6c). Compound 6c was prepared in a similar manner
as 6a from compound 5 (272 mg, 0.50 mmol) and (6-tert-
butylphenanthren-2-yl)pinacolborane22 (1.08 g, 3.00 mmol) and was
obtained as a light-yellow solid (81 mg, 0.07 mmol, 13%). Mp: >360
Synthesis of Compound 4. Compound 3 (1.63 g, 5.43 mmol)
was dissolved in MeOH/CH2Cl2 (100 mL/100 mL) and then K2CO3
was added (75 mg, 0.54 mmol); the resulting solution was stirred for 3
h. The solution was treated with water and extracted with
dichloromethane (3 × 40 mL). The combined organic phases were
dried over MgSO4 and evaporated to dryness. The crude product was
purified on a flash silica gel column (hexane) to afford a yellow oil.
This oil was treated with dry toluene (300 mL) and PtCl2 (143 mg,
0.54 mmol) under an argon atmosphere at 85 °C for 8 h. The resulting
solution was extracted with dichloromethane. The extract was dried
over MgSO4, concentrated under reduced pressure, and purified on a
silica gel column (dichloromethane/hexane 1/10) to afford chrysene
(4) (1.05 g, 4.62 mmol, 85%) as a light-yellow solid. Mp: 254−255 °C.
1H NMR (400 MHz, CDCl3): δ 8.76 (d, J = 8.4 Hz, 2H), 8.70 (d, J =
1
°C. H NMR (400 MHz, CDCl3): δ 9.29 (s, 2H), 9.01 (s, 2H), 8.97
(d, J = 8.7 Hz, 2H), 8.82 (d, J = 8.7 Hz, 2H), 8.81 (s, 2H), 8.68 (s,
2H), 8.29−8.25 (m, 6H), 8.11 (dd, J = 1.8, 8.6 Hz, 2H), 8.04 (dd, J =
1.8, 8.4 Hz, 2H), 8.01 (dd, J = 1.6, 8.6 Hz, 2H), 7.91 (d, J = 8.4 Hz,
2H), 7.86−7.66 (m, 14H), 1.55 (s, 18H), 1.48 (s, 18H). 13C NMR
(100 MHz, CDCl3): δ 149.7, 149.5, 139.2, 139.2, 139.0, 132.6, 132.4,
131.4, 130.6, 130.2, 130.1, 129.9, 129.9, 129.9, 129.8, 129.8, 128.8,
128.4, 128.3, 128.1, 127.8, 127.3, 127.2, 127.1, 126.5, 126.3, 126.3,
126.3, 126.0, 125.1, 125.0, 123.4, 122.7, 122.6, 122.1, 118.4, 118.3,
35.3, 35.2, 31.6, 31.5. MALDI-TOF-MS Calcd for C90H76: 1156.5947.
Found: 1156.426. Anal. Calcd for C90H76: C, 93.38; H, 6.62. Found: C,
93.29; H, 6.55.
Synthesis of 3,6,9,12-Tetrakis(7-tert-butylpyren-1-yl)-
chrysene (6d). Compound 6d was prepared in a similar manner as
6a from compound 5 (290 mg, 0.52 mmol) and (7-tert-butylpyren-1-
yl)pinacolborane23 (1.20 g, 3.12 mmol) and was obtained as a light-
9.0 Hz, 2 H), 8.01−7.97 (m, 4H), 7.71−7.67 (m, 2H), 7.64−7.60 (m,
2H). 13C NMR (100 MHz, CDCl3): δ 132.2, 130.6, 128.5, 128.2,
127.3, 126.7, 126.4, 123.1, 121.2. HRMS Calcd for C18H12: 228.0939.
Found: 228.0942. The spectral data agree satisfactorily with a literature
report.27
1
yellow solid (63 mg, 0.05 mmol, 10%). Mp: >360 °C. H NMR (400
MHz, CDCl3): δ 9.18 (s, 2H), 9.11 (s, 2H), 8.33 (dd, J = 2.2, 7.8 Hz,
2H), 8.25−8.19 (m, 8H), 8.16−8.06 (m, 12H), 8.01−7.91 (m, 10H),
7.73 (dd, J = 8.7, 12 Hz, 4H), 1.57 (s, 9H), 1.56 (s, 9H), 1.52 (s, 18H).
13C NMR (100 MHz, CDCl3): δ 149.3, 149.1, 139.9, 138.4, 137.4,
135.9, 131.7, 131.3, 131.3, 131.0, 130.9, 130.9, 130.8, 130.6, 130.0,
129.5, 128.4, 128.2, 127.9, 127.9, 127.8, 127.6, 127.5, 127.3, 127.2,
125.8, 125.7, 125.3, 125.0, 124.9, 124.8, 124.5, 124.5, 123.8, 123.1,
123.0, 122.6, 122.5, 122.4, 122.4, 122.1, 35.2, 35.2, 31.9, 31.9. MALDI-
TOF-MS Calcd for C98H76: 1252.5947. Found: 1252.286. Anal. Calcd
for C98H76: C, 93.89; H, 6.11. Found: C, 93.55; H, 6.14.
Synthesis of (4-tert-Butylnaphthalen-1-yl)pinacolborane. To
a 1,4-dioxane solution (50 mL) of Pd(dppf)Cl2 (146 mg, 0.2 mmol)
and KOAc (1.12 g, 12 mmol) were added 1-bromo-4-tert-
butylnaphthalene (1.05 g, 4.0 mmol) and bis(pinacolato)diboron
(1.29 g, 4.8 mmol); the mixture was stirred for 3 h at 80 °C. The
solution was extracted with dichloromethane, and the extract was
washed with water, dried over MgSO4, and concentrated. The residues
were purified by silica gel column chromatography (ethyl acetate/
hexane 1/10) to afford the desired borane compound (1.15 g, 3.73
mmol, 93%) as a white solid. Mp: 140−146 °C. 1H NMR (400 MHz,
CDCl3): δ 8.82 (dd, J = 2.4, 7.6 Hz, 1H), 8.46 (dd, J = 2.0, 7.6 Hz,
1H), 7.99 (d, J = 7.6 Hz, 1H), 7.50−7.45 (m, 3H), 1.61 (s, 9H), 1.39
(s, 12H). 13C NMR (100 MHz, CDCl3): δ 149.6, 138.4, 135.4, 131.3,
129.8, 126.9, 125.0, 124.1, 122.4, 83.5, 36.1, 31.8, 24.9. HRMS Calcd
for C20H27BO2: 310.2104. Found: 310.2109.
Synthesis of 3,6,9,12-Tetrakis((triisopropylsilyl)ethynyl)-
chrysene (6e). Compound 5 (300 mg, 0.55 mmol), Pd(PPh3)4
(130 mg, 0.11 mmol), CuI (42 mg, 0.22 mmol), and PPh3 (58 mg,
0.22 mmol) were dissolved in a solution of piperidine (7.5 mL) and
triethylamine (22.5 mL); the mixture was stirred for 5 min. To this
mixture was added (triisopropylsilyl)acetylene (1.094 g, 6.00 mmol)
dropwise under a nitrogen atmosphere; the resulting solution was
heated to 80 °C for 8 h. After the solution was cooled to room
temperature, the solvent was removed under reduced pressure. The
residues were eluted through a long silica gel column (hexane) to give
compound 6e (151 mg, 0.16 mmol, 29%) as a white solid. Mp: >260
Synthesis of 3,6,9,12-Tetrakis(3,5-di-tert-butylphenyl)-
chrysene (6a). Nitrogen was bubbled through a mixed solution of
toluene (40 mL), EtOH (10 mL), and water (10 mL) for 30 min, and
to this solution were added compound 5 (875 mg, 1.61 mmol),
Pd(PPh3)4 (379 mg, 0.32 mmol), Na2CO3 (10.239 g, 96.60 mmol),
and 3,5-di-tert-butylphenylpinacolborane21 (3.055 g, 9.66 mmol). The
mixture was heated at 80 °C for 24 h. The solution was extracted with
hexane, concentrated, and purified by silica gel column chromatog-
raphy (dichloromethane/hexane 1/10) to afford compound 8a (427
1
°C. H NMR (400 MHz, CDCl3): δ 8.85 (s, 2H), 8.82 (s, 2H), 8.48
(d, J = 8.4 Hz, 2H), 7.78 (dd, J = 1.2, 8.4 Hz, 2H), 1.23−1.18 (m,
42H). 13C NMR (100 MHz, CDCl3): δ 131.4, 130.6, 129.4, 127.5,
127.0, 127.0, 126.8, 122.5, 121.2, 107.4, 104.9, 97.7, 92.5, 18.8, 18.7,
11.5, 11.4. MALDI-TOF-MS Calcd for C62H92Si4: 948.6276. Found:
948.547. Anal. Calcd for C62H92Si4: C, 78.41; H, 9.76. Found: C,
78.32; H, 9.69.
1
mg, 0.43 mmol, 27%) as a white solid. Mp: >350 °C. H NMR (400
MHz, CDCl3): δ 9.04 (d, J = 1.2 Hz, 2H), 8.79 (s, 2H), 8.21 (d, J = 8.6
Hz, 2H), 7.82 (dd, J = 1.6, 8.6 Hz, 2H), 7.60 (d, J = 1.8 Hz, 4H), 7.57
(d, J = 1.8 Hz, 4H), 7.55 (t, J = 1.8 Hz, 2H), 7.47 (t, J = 1.8 Hz, 2H),
1.43 (s, 36 H), 1.40 (s, 36 H). 13C NMR (100 MHz, CDCl3): δ 151.3,
150.8, 141.0, 140.5, 140.4, 139.9, 131.4, 130.2, 127.8, 127.5, 126.4,
124.8, 124.8, 122.2, 122.2, 121.6, 121.3, 35.1, 35.1, 31.7, 31.6. MALDI-
TOF-MS Calcd for C74H92: 980.7199. Found: 980.523. Anal. Calcd for
C74H92: C, 90.55; H, 9.45. Found: C, 90.47; H, 9.50.
Synthesis of 3,6,9,12-Tetrakis(4-tert-butylnaphthalen-1-yl)-
chrysene (6b). Compound 6b was prepared in a similar manner as 6a
from compound 5 (652 mg, 1.20 mmol) and (4-tert-butylnaphthalen-
1-yl)pinacolborane (2.23 g, 7.20 mmol) and was obtained as white
solid (172 mg, 0.18 mmol, 15%). Mp: >355 °C. 1H NMR (400 MHz,
CDCl3): δ 8.87 (s, 2H), 8.80 (s, 2H), 8.58 (d, J = 8.8 Hz, 2H), 8.50 (d,
J = 8.8 Hz, 2H), 7.97 (d, J = 8.4 Hz, 2H), 7.71−7.43 (m, 18H), 7.35−
7.29 (m, 4H), 1.72 (s, 18H), 1.64 (s, 18H). 13C NMR (100 MHz,
CDCl3): δ 146.2, 145.8, 139.6, 139.2, 138.1, 137.6, 134.5, 133.2, 131.7,
131.7, 131.5, 130.6, 128.9, 128.3, 127.9, 127.6, 127.5, 127.5, 127.2,
127.1, 127.1, 126.8, 124.8, 124.8, 124.4, 124.3, 123.2, 122.9, 122.8,
36.1, 36.0, 32.0, 31.9. MALDI-TOF-MS Calcd for C74H68: 956.5321.
Found: 956.497. Anal. Calcd for C74H68: C, 92.84; H, 7.16. Found: C,
92.46; H, 7.20.
Synthesis of 3,6,9,12-Tetrakis((3,5-di-tert-butylphenyl)-
ethynyl)chrysene (6f). Compound 5 (250 mg, 0.46 mmol),
Pd(PPh3)4 (107 mg, 0.09 mmol), CuI (34 mg, 0.18 mmol), and
PPh3 (47 mg, 0.18 mmol) were dissolved in a solution of piperidine (6
mL) and triethylamine (18 mL); the mixture was stirred for 5 min. To
this mixture was added 1,3-di-tert-butyl-5-ethynylbenzene24 (887 mg,
4.14 mmol) dropwise under a nitrogen atmosphere; the resulting
solution was heated to 80 °C for 8 h. The resulting solution was
cooled to room temperature, and the solvent was removed under
reduced pressure. The residues were eluted through an alumina
column (hexane) to give compound 6f (108 mg, 0.10 mmol, 22%) as a
1
yellow solid. Mp: >280 °C. H NMR (400 MHz, CDCl3): δ 9.03 (s,
2H), 9.02 (s, 2H), 8.60 (d, J = 8.4 Hz, 2H), 7.89 (d, J = 8.4 Hz, 2H),
7.58 (d, J = 1.7 Hz, 4H), 7.50 (d, J = 1.7 Hz, 4H), 7.48 (s, 2H), 7.44
(s, 2H), 1.39 (s, 36H), 1.36 (s, 36H). 13C NMR (100 MHz, CDCl3): δ
151.1, 151.0, 131.1, 129.9, 129.7, 127.6, 127.2, 127.0, 126.3, 126.1,
126.1, 123.3, 123.0, 122.6, 122.1, 122.0, 121.2, 96.6, 92.0, 88.7, 86.6,
34.9, 34.9, 31.4, 31.4. MALDI-TOF-MS Calcd for C82H92: 1076.7199.
Found: 1076.755. Anal. Calcd for C82H92: C, 91.39; H, 8.61. Found: C,
91.51; H, 8.32.
272
dx.doi.org/10.1021/jo402429q | J. Org. Chem. 2014, 79, 267−274